Institut fuer Frauengesundheit
Quick facts
Marketed products
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Institut fuer Frauengesundheit portfolio CI brief
- Institut fuer Frauengesundheit pipeline updates RSS
Frequently asked questions about Institut fuer Frauengesundheit
What are Institut fuer Frauengesundheit's marketed drugs?
Top marketed products include Eribulin Injection [Halaven], Ontruzant.
Related
- Eribulin Injection [Halaven]
- Ontruzant · Other
- Sector hub: All tracked pharma companies